5% Topical imiquimod tolerance in transplant recipients

Dermatology

Volumn 215, Issue 2, 2007, Pages 130-133

  Ben M'barek, Lilia ^a   Mebazaa, Amel ^a   Euvrard, Sylvie ^e   Frances, Camille ^b   Thervet, Eric ^c   Morel, Patrice ^a   Menasché, Suzanne ^d   Legendre, Christophe ^c   Lebbe, Celeste ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e South Lyon Hospital   (France)

Author keywords

Actinic keratosis; Immunomodulator; Transplant recipient; Warts

Indexed keywords

IMIQUIMOD; IMMUNOMODULATING AGENT;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BOWENOID PAPULOSIS; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; ERYTHEMA; FEMALE; GRAFT RECIPIENT; HEART GRAFT; HUMAN; IMMUNOMODULATION; KIDNEY GRAFT; KIDNEY PANCREAS TRANSPLANTATION; MALE; PRIORITY JOURNAL; PRURITUS; RETROSPECTIVE STUDY; SKIN BURNING SENSATION; TIME SERIES ANALYSIS; TREATMENT DURATION; TREATMENT RESPONSE; VERRUCA VULGARIS;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; ADULT; AGED; AMINOQUINOLINES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; KERATOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN; SKIN NEOPLASMS; TRANSPLANTATION; TREATMENT OUTCOME; ULTRAVIOLET RAYS; WARTS;

EID: 34547822013     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104264     Document Type: Article

References (19)

1. Kovach BT, Stasko T: Use of topical immunomodulators in organ transplant recipients. Dermatol Ther 2005;18:19-27.
2. Mirza B, De'Ambrosis B: Treatment of facial superficial basal cell carcinoma with imiquimod 5% cream. Clin Exp Dermatol 2003;28:16-18.
3. Stockfleth E, Meyer T, Benninghoff B, Christophers E: Successful treatment of actinic keratosis with imiquimod cream 5%: a report of 6 cases. Br J Dermatol 2001;144:1050-1058.
4. Harwood CA, Perrett CM, Brown VL, Leigh IM, McGregor JM, Proby CM: Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed individuals. Br J Dermatol 2005;152:122-129.
5. Brown VL, Atkins CL, Ghali L, Cerio R, Harwood CA, Proby CM: Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial. Arch Dermatol 2005;141:985-993.
6. Gilson RJ, Shupack JL, Friedman-Kien AE, Conant MA, Weber JN, Nayagam AT, et al: A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group. AIDS 1999;13:2397-2404.
7. Ulrich C, Busch JO, Meyer T, Nindl I, Schmook W, Sterry W, Stockfleth E: Successful treatment of multiple actinic keratosis in organ transplant patients with topical 5% imiquimod: a report of six cases. Br J Dermatol 2006;155:451-454.
8. Smith KJ, Germain M, Skelton H: Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy. Dermatol Surg 2001;27:561-564.
9. Prinz BM, Hafner J, Dummer R, Burg G, et al: Treatment of Bowen's disease with 5% imiquimod cream in transplant recipients. Transplantation 2004:77:790-791.
10. Lebwohl M, Dinehart S, Whiting D, Lee PK, Tawfik N, Jorizzo J, Lee JH, Fox TL: Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol 2004;50:714-721.
11. Szeimies RM, Gerritsen MJ, Gupta G, Ortonne JP, Serresi S, Bichel J, et al: Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. J Am Acad Dermatol 2004;51:547-555.
12. Godfrey JC, Vaughan MC, Williams JV: Successful treatment of bowenoid papulosis in a 9-year-old girl with vertically acquired human immunodeficiency virus. Pediatrics 2003;112:73-76.
13. Redondo P, Lloret P: Topical imiquimod for bowenoid papulosis in an HIV-positive woman. Acta Derm Venereol 2002;82:212-213.
14. Richter ON, Petrow W, Wardelmann E, Dorn C, Kupka M, Ulrich U: Bowenoid papulosis of the vulva - Immunotherapeutical approach with topical imiquimod. Arch Gynecol Obstet 2003;268:333-336.
15. Yan J, Chen SL, Wang HN, Wu TX: Meta-analysis of 5% imiquimod and 0.5% podophyllotoxin in the treatment of condylomata acuminata. Dermatology 2006;213:218-223.
16. Gayed SL: Topical imiquimod cream 5% for resistant perianal warts in a renal transplant patient. Int J STD AIDS 2002;13:349-351.
17. Cusini M, Salmaso F, Zerboni R, Carminati G, Franchi C, Locatelli A: 5% imiquimod cream for external anogenital warts in HIV-infected patients under HAART therapy. Int J STD AIDS 2004;15:17-20.
18. Hengge UR, Esser S, Schultewolter T, Behrendt C, Meyer T, Stockfleth E, Goos M: Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol 2000;143:1026-1031.
19. Grussendorf-Conen EI, Jacobs S, Rubben A, Dethlefsen U: Topical 5% imiquimod long-term treatment of cutaneous warts resistant to standard therapy modalities. Dermatology 2002;205:139-145.